PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.7K Hold
200
0.01% 392
2026
Q1
$14.4K Hold
200
﹤0.01% 381
2025
Q4
$15.9K Hold
200
﹤0.01% 386
2025
Q3
$15.1K Hold
200
﹤0.01% 374
2025
Q2
$13.8K Hold
200
﹤0.01% 344
2025
Q1
$13.6K Hold
200
0.01% 349
2024
Q4
$8.98K Sell
200
-317
-61% -$17.8K ﹤0.01% 370
2024
Q3
$32.5K Hold
517
0.02% 256
2024
Q2
$30.5K Hold
517
0.02% 237
2024
Q1
$41.2K Sell
517
-2,555
-83% -$195K 0.03% 211
2023
Q4
$243K Sell
3,072
-246
-7% -$17.5K 0.15% 78
2023
Q3
$232K Sell
3,318
-48
-1% -$3.4K 0.17% 75
2023
Q2
$233K Buy
3,366
+69
+2% +$4.91K 0.17% 73
2023
Q1
$245K Buy
3,297
+621
+23% +$52.1K 0.19% 67
2022
Q4
$249K Buy
+2,676
New +$258K 0.21% 62

Other funds holding CVS

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s CVS Position: Q2 2026 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. held its CVS Health (CVS) position steady in Q2 2026 at 200 shares worth $20.7K. The position accounts for 0.01% of the portfolio, ranked #392.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in CVS in Q4 2022 and has held it in 15 quarters since. The position peaked at $249K in Q4 2022. 1,271 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. held 200 shares of CVS Health worth $20.7K as of Q2 2026.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.01% of PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s portfolio in Q2 2026, its #392 holding.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in CVS Health in Q4 2022 and has held it in 15 quarters since.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s CVS Health position peaked at $249K in Q4 2022.
  • 1,271 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q2 2026, filed 7 Aug 2026.